Impact Factor
3.23
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.69
299 total citations
h5-index
22
h5 depth signal
Cited share
76.3%
90 of 118
Total citations
299
Citation footprint
Metric signal
2.19
External metric anchor
Self-citation
1.3%
4 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
172
China
158
Germany
63
Japan
57
India
55
Citing Fields of Research
Pharmacology & Toxicology
299
Cancer Drugs
144
Antibiotic & Antibacterial Agents
70
Drug Delivery Systems
58
Cardiology
36
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,668
Articles tracked across the journal lifetime
Indexed publication set
118
90 cited publications
Last 12 months
70
5.8 publications/month
Open access share
35.7%
25 OA publications in the last year
Leading citing country
United States
172 citing publications
Leading citing field
Pharmacology & Toxicology
299 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v4n1, 1979-
v4n1, 1979-
Active Coverage
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Antibiotic & Antibacterial Agents
Anesthetic & Pain Medicine
Transplantation
Cancer Drugs
Hematology
Broad Categories
Pharmacology
Pharmacology & Toxicology
Cancer Drugs
Antibiotic & Antibacterial Agents
Hematology
Drug Delivery Systems
Substance Abuse
MeSH Descriptors
Kinetics
Pharmaceutical Preparations
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s13318-026-01042-w
Open DOI
PBPK Modeling of Varenicline: Relating Variable Pharmacokinetics to Genomics
02
DOI 10.1007/s13318-026-01041-x
Open DOI
Model-Based Evaluation of the Warfarin–Sulfamethoxazole Drug–Drug Interaction
03
04
05
06
07
08
DOI 10.1007/s13318-026-01035-9
Open DOI
Population Pharmacokinetic Analysis of Everolimus Based on Albumin–Bilirubin Scores in Kidney Transplant Recipients
09
DOI 10.1007/s13318-026-01034-w
Open DOI
Population Pharmacokinetics of Savolitinib and Its Active Metabolite M2 in Patients with Advanced Solid Tumour
10
Bibliographical & Catalog Notes
Also issued online.
Vol. 10, no. 1 (1985)19920916 Notice not published Printed on acid-free paper